Clinical Trial Update: Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating magnesium sulfate to prevent post-ERCP pancreatitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University Medicine Greifswald | Conditions: Post-ERCP Pancreatitis | Phase 3 | Status: TERMINATED